LPL Financial LLC Grows Stake in Davis Select U.S. Equity ETF (DUSA)

LPL Financial LLC grew its holdings in shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA) by 29.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,363 shares of the healthcare company’s stock after purchasing an additional 7,194 shares during the quarter. LPL Financial LLC owned approximately 0.70% of Davis Select U.S. Equity ETF worth $734,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Raymond James Financial Services Advisors Inc. purchased a new stake in shares of Davis Select U.S. Equity ETF during the 4th quarter valued at about $202,000. Private Advisor Group LLC purchased a new stake in shares of Davis Select U.S. Equity ETF during the 3rd quarter valued at about $240,000. Jane Street Group LLC purchased a new stake in shares of Davis Select U.S. Equity ETF during the 3rd quarter valued at about $306,000. Finally, D.A. Davidson & CO. increased its position in shares of Davis Select U.S. Equity ETF by 36.8% during the 4th quarter. D.A. Davidson & CO. now owns 31,755 shares of the healthcare company’s stock valued at $743,000 after purchasing an additional 8,535 shares during the last quarter.

NASDAQ DUSA opened at $23.21 on Friday. Davis Select U.S. Equity ETF has a 52 week low of $20.06 and a 52 week high of $25.32.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://dakotafinancialnews.com/2018/04/14/lpl-financial-llc-grows-stake-in-davis-select-u-s-equity-etf-dusa.html.



Davis Select U.S. Equity ETF Profile

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

Institutional Ownership by Quarter for Davis Select U.S. Equity ETF (NASDAQ:DUSA)

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply